Efficacy and Safety of Hypofractionated Stereotactic Radiotherapy for Recurrent Malignant Gliomas: A Systematic Review and Meta-analysis
- 1 July 2019
- journal article
- review article
- Published by Elsevier in World Neurosurgery
- Vol. 127, 176-185
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Safety and Efficacy of Stereotactic Radiosurgery and Adjuvant Bevacizumab in Patients With Recurrent Malignant GliomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Irradiation and Bevacizumab in High-Grade Glioma Retreatment SettingsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Scale to Predict Survival After Surgery for Recurrent Glioblastoma MultiformeJournal of Clinical Oncology, 2010
- Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade GliomasJournal of Clinical Oncology, 2010
- Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of recurrent glioblastoma multiformeNeurosurgical Focus, 2009
- Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant GliomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomasCancer, 2008
- Reirradiation Tolerance of the Human BrainInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- ‘Recurrent’ glioblastoma multiforme, when should we reoperate?British Journal Of Neurosurgery, 2008
- Comparison of Stereotactic Radiosurgery and Brachytherapy in the Treatment of Recurrent Glioblastoma MultiformeNeurosurgery, 1995